These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 29923556)

  • 1. Regulating the Golgi apparatus by co-delivery of a COX-2 inhibitor and Brefeldin A for suppression of tumor metastasis.
    Yu RY; Xing L; Cui PF; Qiao JB; He YJ; Chang X; Zhou TJ; Jin QR; Jiang HL; Xiao Y
    Biomater Sci; 2018 Jul; 6(8):2144-2155. PubMed ID: 29923556
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stable and sustained release liposomal formulations of celecoxib: In vitro and in vivo anti-tumor evaluation.
    Matbou Riahi M; Sahebkar A; Sadri K; Nikoofal-Sahlabadi S; Jaafari MR
    Int J Pharm; 2018 Apr; 540(1-2):89-97. PubMed ID: 29371019
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A pH-sensitive nanotherapeutic system based on a marine sulfated polysaccharide for the treatment of metastatic breast cancer through combining chemotherapy and COX-2 inhibition.
    Zhang T; Liu H; Li Y; Li C; Wan G; Chen B; Li C; Wang Y
    Acta Biomater; 2019 Nov; 99():412-425. PubMed ID: 31494294
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional disruption of the Golgi apparatus protein ARF1 sensitizes MDA-MB-231 breast cancer cells to the antitumor drugs Actinomycin D and Vinblastine through ERK and AKT signaling.
    Luchsinger C; Aguilar M; Burgos PV; Ehrenfeld P; Mardones GA
    PLoS One; 2018; 13(4):e0195401. PubMed ID: 29614107
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidermal growth factor receptor-targeted immunoliposomes for delivery of celecoxib to cancer cells.
    Limasale YD; Tezcaner A; Özen C; Keskin D; Banerjee S
    Int J Pharm; 2015 Feb; 479(2):364-73. PubMed ID: 25595386
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of vesicle transport and cell motility by Golgi-localized Dbs.
    Fitzpatrick ER; Hu T; Ciccarelli BT; Whitehead IP
    Small GTPases; 2014; 5(4):1-12. PubMed ID: 25483302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Processing to endoglycosidase H-resistant thyrotropin subunits occurs in the presence of brefeldin-A: evidence favoring the recycling of Golgi membranes to the rough endoplasmic reticulum in mouse thyrotrophs.
    Johnson MJ; Miura Y; Rubin D; Magner JA
    Thyroid; 1991; 1(2):185-94. PubMed ID: 1822366
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synergistic inhibition of breast cancer metastasis by silibinin-loaded lipid nanoparticles containing TPGS.
    Xu P; Yin Q; Shen J; Chen L; Yu H; Zhang Z; Li Y
    Int J Pharm; 2013 Sep; 454(1):21-30. PubMed ID: 23830941
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low molecular weight heparin-based reduction-sensitive nanoparticles for antitumor and anti-metastasis of orthotopic breast cancer.
    Sun H; Cao D; Liu Y; Wang H; Ke X; Ci T
    Biomater Sci; 2018 Jul; 6(8):2172-2188. PubMed ID: 29942949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyaluronic acid-modified liposomal honokiol nanocarrier: Enhance anti-metastasis and antitumor efficacy against breast cancer.
    Wang J; Liu D; Guan S; Zhu W; Fan L; Zhang Q; Cai D
    Carbohydr Polym; 2020 May; 235():115981. PubMed ID: 32122511
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Golgi-related structure remains after the brefeldin A-induced formation of an ER-Golgi hybrid compartment.
    De Lemos-Chiarandini C; Ivessa NE; Black VH; Tsao YS; Gumper I; Kreibich G
    Eur J Cell Biol; 1992 Aug; 58(2):187-201. PubMed ID: 1425761
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative Evaluation of Nimesulide-Loaded Nanoparticles for Anticancer Activity Against Breast Cancer Cells.
    Sengel-Turk CT; Hascicek C; Bakar F; Simsek E
    AAPS PharmSciTech; 2017 Feb; 18(2):393-403. PubMed ID: 27007742
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hydrophobic interaction mediating self-assembled nanoparticles of succinobucol suppress lung metastasis of breast cancer by inhibition of VCAM-1 expression.
    Cao H; Zhang Z; Zhao S; He X; Yu H; Yin Q; Zhang Z; Gu W; Chen L; Li Y
    J Control Release; 2015 May; 205():162-71. PubMed ID: 25598420
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Curcumin-Celecoxib: a synergistic and rationale combination chemotherapy for breast cancer.
    Alqahtani AM; Chidambaram K; Pino-Figueroa A; Chandrasekaran B; Dhanaraj P; Venkatesan K
    Eur Rev Med Pharmacol Sci; 2021 Feb; 25(4):1916-1927. PubMed ID: 33660801
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treating breast cancer metastasis with cabazitaxel-loaded polymeric micelles.
    Zhong T; He B; Cao HQ; Tan T; Hu HY; Li YP; Zhang ZW
    Acta Pharmacol Sin; 2017 Jun; 38(6):924-930. PubMed ID: 28504249
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BFA-induced compartments from the Golgi apparatus and trans-Golgi network/early endosome are distinct in plant cells.
    Lam SK; Cai Y; Tse YC; Wang J; Law AH; Pimpl P; Chan HY; Xia J; Jiang L
    Plant J; 2009 Dec; 60(5):865-81. PubMed ID: 19709389
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of Brefeldin A on the Golgi complex, endoplasmic reticulum and viral envelope glycoproteins in murine erythroleukemia cells.
    Ulmer JB; Palade GE
    Eur J Cell Biol; 1991 Feb; 54(1):38-54. PubMed ID: 2032551
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pulmonary surfactant phosphatidylcholine transport bypasses the brefeldin A sensitive compartment of alveolar type II cells.
    Osanai K; Mason RJ; Voelker DR
    Biochim Biophys Acta; 2001 Apr; 1531(3):222-9. PubMed ID: 11325613
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell survival and protein secretion associated with Golgi integrity in response to Golgi stress-inducing agents.
    Ignashkova TI; Gendarme M; Peschk K; Eggenweiler HM; Lindemann RK; Reiling JH
    Traffic; 2017 Aug; 18(8):530-544. PubMed ID: 28485883
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sulfation in the Golgi lumen of Madin-Darby canine kidney cells is inhibited by brefeldin A and depends on a factor present in the cytoplasm and on Golgi membranes.
    Fjeldstad K; Pedersen ME; Vuong TT; Kolset SO; Nordstrand LM; Prydz K
    J Biol Chem; 2002 Sep; 277(39):36272-9. PubMed ID: 12138122
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.